CN Patent

CN120789028A — 具有精确的活性物溶出谱的口腔膜组合物和剂型

Assigned to Aquitif Therapy Co · Expires 2025-10-17 · 1y expired

What this patent protects

本申请涉及具有精确的活性物溶出谱的口腔膜组合物和剂型。本文中公开了用于递送一种或更多种活性物的单独单位剂量的口腔膜，所述膜具有精确计算和受控的活性物溶出谱。可使用广泛多种活性物，包括例如氯巴占、地西泮或利鲁唑。还公开了通过施用本文中公开的口腔膜来治疗多种疾病和病症例如癫痫和癫痫发作的方法。

USPTO Abstract

本申请涉及具有精确的活性物溶出谱的口腔膜组合物和剂型。本文中公开了用于递送一种或更多种活性物的单独单位剂量的口腔膜，所述膜具有精确计算和受控的活性物溶出谱。可使用广泛多种活性物，包括例如氯巴占、地西泮或利鲁唑。还公开了通过施用本文中公开的口腔膜来治疗多种疾病和病症例如癫痫和癫痫发作的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN120789028A
Jurisdiction
CN
Classification
—
Expires
2025-10-17
Drug substance claim
No
Drug product claim
No
Assignee
Aquitif Therapy Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.